Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | RGT-419B |
| Trade Name | |
| Synonyms | RGT419B|RGT 419B|GDC-4198|GDC4198|GDC 4198|RO7840734 |
| Drug Descriptions |
RGT-419B is a third-generation CDK inhibitor with activity against CDK2, CDK4, and CDK6, which potentially inhibits proliferation of tumor cells and tumor growth (Cancer Res 2021;81(4 Suppl):Abstract nr PS16-22). |
| DrugClasses | CDK2 Inhibitor 31 CDK4 Inhibitor 18 CDK6 Inhibitor 6 |
| CAS Registry Number | NA |
| NCIT ID | C188891 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Giredestrant + RGT-419B | Giredestrant RGT-419B | 0 | 1 |
| RGT-419B | RGT-419B | 0 | 1 |